Bottega Roberta, Marconi Caterina, Faleschini Michela, Baj Gabriele, Cagioni Claudia, Pecci Alessandro, Pippucci Tommaso, Ramenghi Ugo, Pardini Simonetta, Ngu Loretta, Baronci Carlo, Kunishima Shinji, Balduini Carlo L, Seri Marco, Savoia Anna, Noris Patrizia
Institute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico Burlo Garofolo, Trieste, Italy;
Genetica Medica, Dipartimento di Scienze Mediche Chirurgiche, Policlinico Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy;
Blood. 2015 Jan 29;125(5):869-72. doi: 10.1182/blood-2014-08-594531. Epub 2014 Oct 31.
Inherited thrombocytopenias (ITs) are a heterogeneous group of syndromic and nonsyndromic diseases caused by mutations affecting different genes. Alterations of ACTN1, the gene encoding for α-actinin 1, have recently been identified in a few families as being responsible for a mild form of IT (ACTN1-related thrombocytopenia; ACTN1-RT). To better characterize this disease, we screened ACTN1 in 128 probands and found 10 (8 novel) missense heterozygous variants in 11 families. Combining bioinformatics, segregation, and functional studies, we demonstrated that all but 1 amino acid substitution had deleterious effects. The clinical and laboratory findings of 31 affected individuals confirmed that ACTN1-RT is a mild macrothrombocytopenia with low risk for bleeding. Low reticulated platelet counts and only slightly increased serum thrombopoietin levels indicated that the latest phases of megakaryopoiesis were affected. Given its relatively high frequency in our cohort (4.2%), ACTN1-RT has to be taken into consideration in the differential diagnosis of ITs.
遗传性血小板减少症(ITs)是一组由影响不同基因的突变引起的综合征性和非综合征性疾病。编码α-辅肌动蛋白1的基因ACTN1的改变最近在一些家族中被确定为导致轻度IT形式(ACTN1相关血小板减少症;ACTN1-RT)的原因。为了更好地描述这种疾病,我们在128名先证者中筛查了ACTN1,在11个家族中发现了10个(8个新的)错义杂合变异。结合生物信息学、分离分析和功能研究,我们证明除1个氨基酸替代外,所有变异均具有有害作用。31名受影响个体的临床和实验室检查结果证实,ACTN1-RT是一种轻度大血小板减少症,出血风险低。低网织血小板计数和仅略有升高的血清血小板生成素水平表明巨核细胞生成的最后阶段受到影响。鉴于其在我们队列中的相对高频率(4.2%),在ITs的鉴别诊断中必须考虑ACTN1-RT。